Scotiabank downgraded Macerich to Underperform from Sector Perform with a price target of $14, down from $16. The firm cites the company’s “somewhat disappointing” Q1 results and the announcement of its strategic plan to address leverage for the downgrade. Although Scotiabank believes action is needed to address Macerich’s high net debt to EBITDA leverage, it says the path to low-to-mid six-times leverage will result in 3-4 years of earnings headwinds as assets are sold or handed back to lenders. Plus, there is the potential for another round of equity issuance driven shareholder earnings dilution of 10%, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MAC:
- CORRECTION – Macerich Announces Initial Progress in its Path Forward Strategic Plan
- UPDATE – Macerich Announces Initial Progress in its Path Forward Strategic Plan
- Macerich Announces Initial Progress in its Path Forward Strategic Plan
- Macerich announces recent purchases in Arizona, Texas
- Fly Insider: Sensata, BioMarin among week’s notable insider trades
